Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23977)

• Formulation Name: Osimertinib Mesylate eq 40mg base tablet
• Company: Astrazeneca

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Osimertinib	(DMRJLAT)	Non-small-cell lung cancer	2C25.Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferric oxide black	(E00522)	16211978	Colorant
Haematite red	(E00236)	14833	Colorant
Hydroxypropyl cellulose	(E00632)	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent